Review ArticleInternational Journal of Pharmaceutical InvestigationVol. 14 | Issue 1 | 2023 | pp. 39–47Open access
Recently Isolated Fawcettimine-Type Alkaloids
- 1*,
- 1,
- 1,
- 1,
- 1,
- 1
- 1 SEF’s Suryadatta College of Pharmacy, HealthCare & Research (SCPHR), Survey No 342, Bavdhan, Pune, Maharashtra, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Shriniwas Pramod Patil
SEF’s Suryadatta College of Pharmacy, HealthCare & Research (SCPHR), Survey No 342, Bavdhan, Pune, Maharashtra, INDIA.
Email: patilsp111@gmail.com
Copyright: © 2023 Manuscript Technomedia. This is an open access article.
- Published:
- Dec 15, 2023
- Received:
- Jun 9, 2023
- Accepted:
- Oct 25, 2023
- DOI:
- 10.5530/ijpi.14.1.6
How to cite
Patil, S. P., Ramanath, K., Jain, H. K., Pandya, C., Pawar, B., & Pattewar, S. V. (2023). Recently Isolated Fawcettimine-Type Alkaloids. International Journal of Pharmaceutical Investigation, 14(1), 39–47. https://doi.org/10.5530/ijpi.14.1.6
Abstract
Since long back, many Lycopodiaceae or Huperziaceae plants species like Lycopodium clavatum L. serratum, Huperzia serrata, H. carinata, Phlegmariurus squarrosus and P. henryi are being traditionally used in treatment of diseases like Alzheimer’s disease and myasthenia gravis. In pursuit of pharmacologically active molecules, here AChE inhibitors present in any of widely used Lycopodiaceae or Huperziaceae plants species, several researchers successfully isolated hundreds of Lycopidium alkaloids, grouped into four classes, one of which is fawcettimine. This review enlisted all fawcettimine alkaloids, isolation and total laboratory synthesis of which have been reported since 2011 (for ex. fawcettimine, lycoflexine, and lycoposerramine B, Lycopoclavamine-A). It can be concluded that, fawcettimine molecule can used as main nucleus which can used as precursor for synthesize new pharmacologically active moieties.
Keywords
Subject
Article metadata
| Title | Recently Isolated Fawcettimine-Type Alkaloids |
|---|---|
| Authors | Shriniwas Pramod Patil; KV Ramanath; Hemant Kumar Jain; Charu Pandya; Bhagyashree Pawar; Seema V Pattewar |
| Affiliations | SEF’s Suryadatta College of Pharmacy, HealthCare & Research (SCPHR), Survey No 342, Bavdhan, Pune, Maharashtra, INDIA. |
| Corresponding author | patilsp111@gmail.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 14, Issue 1 (2023) |
Also in this issue
- Navigating Global Regulatory Requirements for Generic Drugs: A Comparative Study of MIST, BRICS, and ICH Countriespp. 1–9
- Finerenone as a New Potent Resistant Hypertension Agent: A Reviewpp. 10–15
- An Overview of Complementary Therapies for Effective Diabetes Managementpp. 16–22
- Degradation of Antibiotics by Ultrasound-Assisted Heterogeneous Activation of Persulfate and Peroxymonosulfate: A Reviewpp. 23–29
- Unlocking the Clinical Significance of Cytochrome P450 Enzymespp. 30–38
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026